Elisa Gobbini

6PUBLICATIONS
38CO-AUTHORS
Solid tumoursInnate immunityCellular immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 09, 2026
Neurotropism and Therapeutic Targeting of Brain Metastases in Small Cell Lung Cancer.

|Nov 14, 2025
Dendritic cells: the central partner for cancer immunity.

Léo Laoubi, Elisa Gobbini, Pierre Duplouye

|Jan 08, 2025
The Spatial Organization of cDC1 with CD8+ T Cells is Critical for the Response to Immune Checkpoint Inhibitors in Patients with Melanoma.

Elisa Gobbini, Margaux Hubert, Anne-Claire Doffin

|Apr 07, 2022
Immune Checkpoint Inhibitor Rechallenge and Resumption: a Systematic Review.

Caroline Plazy, Dalil Hannani, Elisa Gobbini

|Apr 19, 2020
IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer.

Margaux Hubert, Elisa Gobbini, Coline Couillault

|Oct 21, 2019
Real-world outcomes according to treatment strategies in ALK-rearranged non-small-cell lung cancer (NSCLC) patients: an Italian retrospective study.

E Gobbini, R Chiari, P Pizzutillo

Pageof 1

Frequent Collaborators

3 joint publications

Margaux Hubert

3 joint publications

Christophe Caux

2 joint publications

Pierre Duplouye

2 joint publications

Justine Berthet